Author

Claire R Shuey

Thomas Jefferson UniversityORCID 0009-0002-4348-7368Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Adam Eugene SnookiD· 1 shared Adam LuginbuhliD· 1 shared Alice P. PentlandiD· 1 shared Amritha AchuthkumariD· 1 shared Ana M PivovarnikiD· 1 shared Andreas MölleriD· 1 shared Jennifer Clare JonesiD· 1 shared Jubin GeorgeiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Adam Eugene SnookORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Translational Opportunity of Engineered IFNγ-eEVs Through Targeted Inhibition of JAK/STAT1 Signaling, Mimicking IVIg Therapy

Kylie E Preihs, Kübra Karagoz, Claire R Shuey, Amritha Achuthkumar, Ana M Pivovarnik, Sophia M. Crocker, Michelle L. Pleet, Jubin George, Robert D. Carlson, Adam Eugene Snook, Adam Luginbuhl, Peter J. Wermuth, Andreas Möller, Jennifer Clare Jones, Larry A. Harshyne, , My G Mahoney

This paper identifies EV-associated cytokines as mediators of IVIg activity, showing that engineered IFNγ-eEVs can suppress IFNγ signaling through context-dependent mechanisms.

bioRxiv · May 3, 2026 · PreprintBioengineering